These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 31036503)

  • 1. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Ma J; An Y; Chen Y; Zhang B; Feng X; Li H; Chen X; Cheng YJ; Gregg EW; Hu Y; Bennett PH; Li G;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):452-461. PubMed ID: 31036503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
    Li G; Zhang P; Wang J; An Y; Gong Q; Gregg EW; Yang W; Zhang B; Shuai Y; Hong J; Engelgau MM; Li H; Roglic G; Hu Y; Bennett PH
    Lancet Diabetes Endocrinol; 2014 Jun; 2(6):474-80. PubMed ID: 24731674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
    Li G; Zhang P; Wang J; Gregg EW; Yang W; Gong Q; Li H; Li H; Jiang Y; An Y; Shuai Y; Zhang B; Zhang J; Thompson TJ; Gerzoff RB; Roglic G; Hu Y; Bennett PH
    Lancet; 2008 May; 371(9626):1783-9. PubMed ID: 18502303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
    Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study.
    Yu L; Wang J; Gong Q; An Y; Chen F; Chen Y; Chen X; He S; Qian X; Chen B; Dong F; Li H; Zhao F; Zhang B; Li G;
    Diabetes Obes Metab; 2024 Apr; 26(4):1188-1196. PubMed ID: 38168886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
    Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
    Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
    Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
    Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.
    Qian X; Wang J; Gong Q; An Y; Feng X; He S; Chen X; Wang W; Zhang L; Hui Y; Zhai X; Zhang B; Chen Y; Li G
    PLoS Med; 2024 Jul; 21(7):e1004419. PubMed ID: 38980837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Gregg EW; Wang J; An Y; Zhang P; Yang W; Li H; Li H; Jiang Y; Shuai Y; Zhang B; Zhang J; Gerzoff RB; Roglic G; Hu Y; Li G; Bennett PH
    Diabetologia; 2011 Feb; 54(2):300-7. PubMed ID: 21046360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
    Yoon U; Kwok LL; Magkidis A
    Metabolism; 2013 Feb; 62(2):303-14. PubMed ID: 22959500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Gregg EW; Cheng YJ; Li G; Bennett PH;
    Diabetes Obes Metab; 2021 Oct; 23(10):2385-2394. PubMed ID: 34212465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of improvement or worsening of glucose tolerance on risk of stroke in persons with impaired glucose tolerance.
    Shen X; Zhang P; Wang J; An Y; Gregg EW; Zhang B; Li H; Gong Q; Chen Y; Shuai Y; Engelgau MM; Hu Y; Bennett PH; Li G
    Int J Stroke; 2018 Dec; 13(9):941-948. PubMed ID: 29956594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
    Zhang L; Zhang Y; Shen S; Wang X; Dong L; Li Q; Ren W; Li Y; Bai J; Gong Q; Kuang H; Qi L; Lu Q; Cheng W; Liu Y; Yan S; Wu D; Fang H; Hou F; Wang Y; Yang Z; Lian X; Du J; Sun N; Ji L; Li G;
    Lancet Diabetes Endocrinol; 2023 Aug; 11(8):567-577. PubMed ID: 37414069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial.
    Saito T; Watanabe M; Nishida J; Izumi T; Omura M; Takagi T; Fukunaga R; Bandai Y; Tajima N; Nakamura Y; Ito M;
    Arch Intern Med; 2011 Aug; 171(15):1352-60. PubMed ID: 21824948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a Community-Based Diabetes Prevention Program in Thailand: A Cluster Randomized Controlled Trial.
    Aekplakorn W; Tantayotai V; Numsangkul S; Tatsato N; Luckanajantachote P; Himathongkam T
    J Prim Care Community Health; 2019; 10():2150132719847374. PubMed ID: 31079517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study.
    Gong Q; Zhang P; Wang J; An Y; Gregg EW; Li H; Zhang B; Shuai Y; Yang W; Chen Y; Liu S; Engelgau MM; Hu Y; Bennett PH; Li G
    Diabetes Care; 2016 Sep; 39(9):1550-5. PubMed ID: 27411697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
    Nathan DM; Bennett PH; Crandall JP; Edelstein SL; Goldberg RB; Kahn SE; Knowler WC; Mather KJ; Mudaliar S; Orchard TJ; Temprosa M; White NH;
    Diabetologia; 2019 Aug; 62(8):1319-1328. PubMed ID: 31270584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance.
    Oldroyd JC; Unwin NC; White M; Mathers JC; Alberti KG
    Diabetes Res Clin Pract; 2006 May; 72(2):117-27. PubMed ID: 16297488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.
    Uusitupa M; Peltonen M; Lindström J; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Valle TT; Eriksson JG; Tuomilehto J;
    PLoS One; 2009 May; 4(5):e5656. PubMed ID: 19479072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.